Public list: Pharma Startups (6570) Neuroscience Startups (947)
NervGen Pharma creates solutions for the treatment of nerve damage. NervGen's core technology focuses on the protein tyrosine phosphatase sigma (PTPσ), a key neural receptor that inhibits nerve regeneration resulting in a loss of function in patient...Show all
Company (IPO / Went public)
Phone: 778-888-4101
Suite 1703, Three Bentall Centre
595 Burrard Street
Vancouver, V7X 1J1
British Columbia, Canada
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|
Title | Application Date | Patent Date | Status (Patent / Application) |
---|